Searchable abstracts of presentations at key conferences in endocrinology

ea0050p184 | Clinical Biochemistry | SFEBES2017

Interference of midodrine and desglymidodrine in a plasma metanephrines LC-MS/MS assay

Boot Christopher , McFadden Martin , Toole Barry

Introduction: Plasma metanephrines (PMETS) are widely used as a first-line investigation for phaeochromocytoma/paraganglioma owing to the high diagnostic sensitivity of the test. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has become the methodology of choice for measuring PMETS due to the high analytical specificity of the technique. However, there have been recent reports of interference in LC-MS/MS PMETS assays by the α1-recept...

ea0050p184 | Clinical Biochemistry | SFEBES2017

Interference of midodrine and desglymidodrine in a plasma metanephrines LC-MS/MS assay

Boot Christopher , McFadden Martin , Toole Barry

Introduction: Plasma metanephrines (PMETS) are widely used as a first-line investigation for phaeochromocytoma/paraganglioma owing to the high diagnostic sensitivity of the test. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has become the methodology of choice for measuring PMETS due to the high analytical specificity of the technique. However, there have been recent reports of interference in LC-MS/MS PMETS assays by the α1-recept...

ea0077lb22 | Late Breaking | SFEBES2021

Effect of Enzalutamide on cortisol dynamics

Abouzaid Mona , Holliday Rachel , Boot Chris , Quinton Richard , Mamoojee Yaasir

Background: Enzalutamide is a next-generation androgen receptor (AR) antagonist, used as a daily oral agent, in the treatment of castration-resistant prostate cancer. Its suppression of 11β-hydroxysteroid dehydrogenase-2 enzyme has been reported in the literature, leading to hypertension through a relative increase in cortisol concentration at the level of the mineralocorticoid receptors. Enzalutamide is also known to be a potent inducer of drug metabolising enzymes (cyto...

ea0081ep664 | Pituitary and Neuroendocrinology | ECE2022

Peak cortisol level on synacthen stimulation test in cushing’s disease

Ali Rashid Razan , Boot Christopher S , James Andy , Mamoojee Yaasir

Background: Diagnostic work-up for Cushing ’s syndrome (CS) can be challenging, with variable performance characteristics on screening tests. We were recently referred a young female patient with Cushing’s disease (CD) due to a microadenoma. She presented with a seizure and initial biochemical work-up included a Synacthen stimulation test (SST). Her peak cortisol rose to over 1,000 nmol/l. Exaggerated response during SST is expected in hyperestrogenic states due to e...

ea0065p30 | Adrenal and Cardiovascular | SFEBES2019

A UK national audit of the laboratory investigation of phaeochromocytoma and paraganglioma

Boot Christopher , Toole Barry , Harris Sharman , Tetlow Lisa

Background: A range of laboratory tests are available for investigation of phaeochromocytoma/paraganglioma (PPGL) and there is scope for significant variation in practice between centres. Endocrine Society Clinical Practice Guidelines make recommendations concerning the laboratory investigation of PPGL. We performed a national audit using these recommendations as audit standards.Methodology: A questionnaire was distributed to all clinical biochemistry de...

ea0038p19 | Clinical biochemistry | SFEBES2015

A comparison of plasma copeptin and AVP responses during saline infusion studies

Boot Christopher , Hughes Louise , Turner Stephen , Ball Stephen , Neely Dermot

Introduction: Copeptin is the C-terminal fragment of proAVP and secreted in equimolar amounts with AVP. While AVP is unstable in vitro and has proved difficult to measure in clinical practice, copeptin is relatively stable and can be measured using an automated immunoassay. Therefore copeptin measurement offers potential as a more practical alternative to the direct measurement of AVP in the investigation of polyuria/polydipsia.Methods: AVP, cop...

ea0038p31 | Clinical biochemistry | SFEBES2015

Single-centre audit of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma

Boot Christopher , Toole Barry , Johnson Sarah , Ball Stephen , Neely Dermot

Introduction: Measurement of plasma metanephrines (PMETS) is widely regarded as one of the best screening tests for phaeochromocytoma/paraganglioma (P/PGL). Current Endocrine Society guidelines recommend that samples for PMETS are ideally collected in the supine position after 30 min rest and interpreted using supine reference ranges, in order to optimise the diagnostic performance of the test. Current practice in our centre is to collect samples for PMETS from seated patients...

ea0051p016 | Gonadal, DSD and reproduction | BSPED2017

Using salivary testosterone measurements to assess androgen deficiency in adults with Duchenne muscular dystrophy (DMD)

Sahun Yolanda Alins , Cheetham Tim , Boot Chris , Straub Vulker , Wood Claire

Background: Many adolescents and young adults with DMD receive long-term glucocorticoids (GC), a well-recognised cause of hypogonadotrophic hypogonadism. Pubertal induction is routinely offered to DMD adolescents in our centre but few individuals remain on supplementation into adulthood and it is unclear whether these men have age-appropriate endogenous testosterone production. Salivary testosterone (SalT) measurement is available but has not been used to assess androgen statu...

ea0081rc2.3 | Rapid Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Diagnostic accuracy of basal cortisol level to predict secondary adrenal insufficiency in patients with pituitary disease

Mathieson Campbell , Ali Rashid Razan , Boot Christopher S , James Andy , Mamoojee Yaasir

Objective: The 250 µg short Synacthen stimulation test (SST) is the most commonly used dynamic assessment to diagnose adrenal insufficiency (AI). There are challenges to the use of the SST in routine clinical practice, including staff and resource limitation in the current COVID-19 pandemic and Synacthen cost. We aimed to investigate the value of basal cortisol level for predicting AI in our selected cohort of patients at risk of secondary adrenal insufficiency from pitui...

ea0050p277 | Neuroendocrinology and Pituitary | SFEBES2017

Copeptin during hypertonic saline infusion in a polyuria/polydipsia syndrome case series

Boot Christopher , James R Andrew , Tsatlidis Vasileios , Gibb Fraser , Green Fiona , Neely R Dermot G

Introduction: Copeptin is the C-terminal fragment of proAVP and provides an alternative measure of AVP secretion. While direct measurement of AVP during hypertonic saline infusion has been recommended as a diagnostic test for diabetes insipidus (DI), the number of reports examining the utility of copeptin in this context is limited. Here we describe a series of cases where measurement of copeptin during saline infusion has contributed to ...